United States· US:50242-115_04e8fab1-279a-466a-a2cf-52a0f9e550bc

Piasky

A crovalimab product containing crovalimab, registered in United States by Genentech, Inc.. The same ATC class is registered in 11 of our 19 countries.

ATC L04AJ07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPiaskyATCL04AJ07REGISTER NO.US:50242-115_04e8fab1…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Crovalimab is registered in 11 of 19 countries.

Countries holding a registration under ATC L04AJ07 (crovalimab), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Crovalimab · ATC L04AJ07

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CROVALIMAB
Manufacturer
Genentech, Inc.
Country
United States (US)
ATC code
L04AJ07
ATC class
Crovalimab
Defined daily dose
24.3 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5024211501
    1 VIAL, SINGLE-USE in 1 CARTON (50242-115-01) / 2 mL in 1 VIAL, SINGLE-USE
  • ndc11
    50242-115-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Crovalimab in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All crovalimab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Piasky
  • Liechtenstein · Piasky
  • Norway · Piasky

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3bd88afa-3cf1-46be-8377-74cee364b8e9
GET /v1/drugs/3bd88afa-3cf1-46be-8377-74cee364b8e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "340",
  "substance": "CROVALIMAB",
  "productndc": "50242-115",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/2mL",
  "application_number": "BLA761388",
  "marketing_category": "BLA"
}

See everything about crovalimab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.